Identifying different states of breast stem cells to develop the novel combination therapies targeting different breast cancer stem cells.
Investigating the combination therapy of PARPi and 17-AAG to target cancer stem cells in Triple-negative breast cancers.
Studying the effects of microRNAs on breast cancer stem cell self-renewal and differentiation, and develop some miRNA-based therapies with nanotechnology.
Studying the tumor microenvironment in regulating breast cancer stem cells
